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SUMMARY
Our ability to modify whole animal genetics has grown considerably in the last 
two decades. We have seen concerns regarding food safety and protection of 
breeding rights of genetically modified animals compel redirection of genetic 
engineering experimentation toward biomedical applications. Indeed, it has 
been nearly twenty years since the first transgenic livestock appeared in 
the literature, yet at this time, there are no commercially viable agricultural 
species. In contrast to commercialization concerns, in a variety of existing 
transgenic animal models, basic research into the regulation and function 
of specific genes (including both gain-of-function and ablation of potentially 
deleterious gene products) has persevered. Pioneering efforts in transgenic 
animal technology have markedly influenced our appreciation of the factors 
that govern gene regulation and expression, and have contributed significantly 
to our understanding of the biology of mammalian development.
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INTRODUCTION
Animal modeling and technologies for genetic 
modification of animals have experienced a 
tremendous growth rate and central presence in 
the sciences over the last 25 years. From the first 
transgenic animal models reported in the early 
1980s, to cloning technologies in the 1990s, to 
the current utilization of functional genomics and 
bioinformatics technologies  genetic engineering 
technologies have and will continue to evolve at an 
ever increasing pace.
Trans genic animals have provided us with powerful 
tools to explore cell ular and physiological processes 
in vivo. We have been able to modify cell-, tissue-, or 
organ-specific gene expression as well as ubiquitous 
(whole-body) expression in literally thousands of 
different animal models that were produced to 
date. There are a multitude of reviews across the 
life sciences that touch on a broad cross-section of 
the sciences, including a number of animal science 
targeted reviews and a number of new references 
since my summary at the 2002 KRIMVA Conference 
(Pinkert et al., 2002; see also, Pinkert, 1994, 2002; 
Houdebine, 1997; Pinkert et al., 1997b, 2002; Pinkert 
and Murray, 1998; Nagy et al., 2003). 
A number of methods exist for gene transfer in 
mammalian species (Table 1). Genetic engineering 
technologies were reported in a variety of farm 
animal species including rabbits, swine, ruminants 
(including sheep, goats and cattle), poultry and fish. 
With advances in the characterization of factors that 
control gene expression, gene transfer technology 
has become an important means of dissecting gene 
regulation and developmental pathways in vivo. 
Normally, endogenous gene function is regulated by 
a variety of molecular factors. Analysis of transgenic 
animals has illustrated molecular underpinnings and 
events associated with developmental timing, tissue 
distribution, and consequences of modifying gene 
expression. Additionally, transgenic animals have also 
proven quite useful in validating a array of in vitro 
and theoretical model systems.
Development of Transgenic Animals. The ability to 
introduce functional genes or to modify endogenous 
genes in animals provides very powerful tools in 
engineering production animals as well as dissecting 
complex biological processes and systems. Transgenic 
animals represent unique models that are custom 
tailored to address specific biological questions. 
Genetic engineering experimentation in farm 
animals can ultimately surpass classical breeding 
practices where long generational intervals will slow 
the rate of genetic improvement. Additionally, with 
evolving technologies, experiments that are proven 
in pilot laboratory animal studies can be validated 
and introduced into livestock species in a very timely 
manner.
Sequentially, early cell biology and both in vitro 
and in vivo studies laid the groundwork for the 
development of the first genetically engineered 
TRANSGENIC ANIMALS. From late 1980 through 1981, six 
different groups reported success at gene transfer and 
the development of transgenic mouse models using 
microinjection or viral transfection protocols. In gene 
transfer, animals harboring new genes (foreign DNA 
sequences integrated into their genome) are referred 
to as transgenic  a term coined by Gordon and 
Ruddle in 1981. The term transgenic has since been 
adapted to include chimeric and knock-out animals in 
which gene(s) have been selectively ablated from the 
host genome (Fig 1; see also Beardmore, 1997).
A few key terms are important in developing an 
appreciation for many of the current state-of-the-art 
technologies in genetic engineering studies (outlined 
in greater detail in Pinkert, 2002; Nagy et al., 2003). 
As noted in previous reviews, GENE TRANSFER is 
defined as one of a set of techniques directed toward 
manipulating biological function via the introduction 
of foreign DNA sequences (genes) into living cells. 
DNA MICROINJECTION is a gene transfer technique 
where DNA constructs (transgenes) are microinjected 
directly into pronuclei or nuclei of fertilized ova 
(zygotes) (Fig. 1 & 2). In contrast, EMBRYONIC 
STEM (ES) CELL TRANSFER involves the transfer and 
incorporation of pluripotent embryonic stem cells 
into developing embryos (Fig. 1). ES cell transfer also 
provides for gene targeting capability (allowing for 
creation of KNOCK-OUT or KNOCK-IN modeling, where 
endogenous genes are selectively ablated or replaced 
Table 1. 
Gene transfer methods. 
Mouse modeling techniques evolved 
from procedures for non-specific 
(whole genome) transfer to the 
transfer of discrete genes and the 
modification of endogenous genes. 
From mice to domestic animal 
studies, significant inroads to existing 
technologies continue to advance 






Embryonic stem (ES) cell transfer
Nuclear transplantation
Spermatozoa - and spermatogonial cell - mediated transfer
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Figure 1. 
DNA microinjection and ES cell transfer in 
mice.
For DNA microinjection, an in vitro culture 
step is not required (left). DNA is injected 
directly into a pronucleus of a zygote. 
Generally, when transgenic mice (represented 
in black) are created by DNA microinjection, 
all of their cells contain the new transgene(s). 
On the right, after clonal selection of 
transfected ES cells, either embryo injection 
or co-culture is employed. The ES cells are 
either injected directly into a host blastocyst 
or co-cultured with 8-cell to morula-stage ova. 
With blastocyst injection, transgenic offspring 
are termed chimeric, as some of the cells 
are derived from the host blastocyst and some 
from the transfected ES cells (denoted by 
mice with black patches). Yet, using co-culture 
and tetraploid ova, founders may be obtained 
and derived completely from the transfected 
ES cells (solid black mice). [Reprinted with 
permission, Pinkert et al., 1997b]
Figure 2. 
Transgenic pig production by DNA 
microinjection. 
In contrast to mouse modeling, for 
microinjection into zygotes (or later-stage ova) 
for most domestic animal species, visualization 
of the pronuclei (or nuclei) is necessary. This 
is accomplished by centrifugation of the ova 
to stratify the opaque lipids (Wall et al., 1985), 
making pronuclei or nuclei readily visible.  
Here, one of six founder pigs is represented as 
transgenic following initial analysis (reprinted 
with permission, Pinkert et al., 1990).
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by modified sequences, respectively). CLONING is 
generally associated with NUCLEAR TRANSFER whereby 
a nucleus provided by a donor cell is introduced into 
an enucleated oocyte (unfertilized ovum) or zygote 
allowing for reprogramming of the developing 
embryo (Fig. 3). Today, a TRANSGENIC ANIMAL can be 
represented as an animal harboring foreign DNA 
sequences integrated into its genome following 
gene transfer, or b) resulting from the molecular 
manipulation of endogenous genomic DNA (hence, 
not only gain-of-function models are represented in 
the definition, but ablation or loss-of-function models 
are included as well). A TRANSGENIC LINE includes the 
founder and any subsequent offspring inheriting the 
specific GERM-LINE manipulation. Lastly, the majority 
of genetic engineering studies have focused all 
attention on nuclear-encoded genes. The NUCLEUS of 
the cell is generally found within a defined nuclear 
envelope within the cell, containing the genetic 
directives of the animal and its development; the 
genome. As we have learned from recent efforts 
at mapping the human and other animal-specific 
genomes  mammalian genomes contain on the 
order of 30,000 genes. However, beyond the nucleus, 
MITOCHONDRIA are found in the cytoplasm of cells, 
are critical in energy production and metabolism, 
and actually code for 37 additional genes. Over the 
course of the last 7 years, mitochondrial populations 
and mitochondrial DNA (mtDNA) genes have become 
targets of genetic engineering research as well.
PRODUCTION OF TRANSGENIC ANIMALS
Mouse Models. The relative importance of using 
particular strains or breeds of animals in gene transfer 
experimentation will vary dramatically according to 
the species under consideration. Probably the most 
complex system is encountered in the production 
of transgenic mice, simply because so much work 
has been done with this species. Well-documented 
differences in reproductive productivity, behavior, 
related husbandry requirements, and responses 
to various experimental procedures influence the 
efficiency and degree of effort associated with 
production of transgenic founder animals.
Beyond the mouse model, other laboratory animal 
species may be necessary to study a particular 
biological phenomenon. However, independent of the 
specific techniques employed, the significance and 
critical importance of optimizing the experimental 
protocols cannot be underestimated. In any given 
strain or species, selection and management of 
donor females that respond well to hormonal 
synchronization and superovulation, embryo 
transfer recipients that are able to carry fetuses to 
term and then care for neonates appropriately, and 
the effective use of males in a breeding regimen will 
all add to the relative experimental efficiencies. In 
turn, transgenic animal protocols developed in mice 
have been modified to accommodate production of 
other transgenic species.
DNA Microinjection. DNA microinjection, prior to 
nuclear transfer in domestic animals, was the most 
direct and reproducible method for producing 
transgenic animals (Fig. 1). DNA microinjection 
generally involves physical injection of a DNA 
construct solution into embryos (Polites and Pinkert, 
2002) (Fig. 1 & 2). It was this technology and the 
dramatic growth characteristics of transgenic mice 
produced by Palmiter and Brinster (Palmiter et al., 
1982; see also Brinster, 1993) that ignited the animal 
science field (Pursel et al., 1989; Wall et al., 1992; 
Pursel and Rexroad, 1993).
Virtually any cloned DNA construct can be used. 
With few exceptions, microinjected gene constructs 
integrate randomly throughout the hosts genome. 
Yet, multiple integration sites per founder are rarely 
observed, with a single chromosomal integration 
Figure 3. 
Nuclear transfer and cloning of sheep. 
Cells from blastocysts (e.g., inner cell mass cells) or other 
somatic tissues are obtained and propagated in culture. These 
cells are used as nucleus donors for transfer into enucleated 
oocytes. In contrast to DNA microinjection, a fusion step 
is generally employed Here, electrofusion is used to fuse 
couplets (transferred nucleus plus enucleated oocyte) that 
are transferred to recipients for the remainder of gestation. 
(reprinted with permission, Pinkert, 2000).
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site the general rule. Host DNA near the site of 
integration frequently undergoes various forms of 
sequence duplication, deletion or rearrangement as a 
result of transgene incorporation. Such alterations, if 
sufficiently drastic, may disrupt the function of host 
genes at the integration site and constitute insertional 
mutagenesis, and result in an aberrant phenotype. 
Such events are generally not purposefully designed, 
but have led to the serendipitous discovery of 
previously unanticipated genes and gene functions. 
Because DNA microinjection is usually accomplished 
in pronuclear zygotes, transgene incorporation occurs 
in essentially every cell in the developing embryo. 
Incorporation of the transgene into cells that will 
eventually contribute to development of germ cells 
(sperm or ova) is a common occurrence with this 
method, and makes heritability of the transgene by 
offspring of (germline-competent) founder animals 
likely within one generation. However, integration 
of the microinjected DNA construct into the hosts 
genome occasionally may be inexplicably delayed. In 
such a case, if cells of the early embryo (blastomeres) 
undergo mitosis before the transgene-integration 
event occurs, some but not all of the cells will contain 
the transgene, and the founder animal, although still 
considered to be transgenic, will be classified as a 
mosaic or chimera.
Retrovirus-Mediated Gene Transfer. Transfer of 
foreign genes into animal genomes has also been 
accomplished using retroviruses (Chan et al., 1998). 
Although embryos can be infected with retroviruses 
up to midgestation, oocytes to 16-cell stage ova 
are generally used for infection with one or more 
recombinant retroviruses containing a foreign gene 
of interest. After infection, the retrovirus produces a 
DNA copy of its RNA genome using the viral enzyme, 
reverse transcriptase. Completion of this process 
requires that the host cell undergoes the S phase 
of the cell cycle. Therefore, retroviruses effectively 
transduce only mitotically active cells. Modifications 
to the retrovirus frequently consist of removal of 
structural genes, such as gag, pol, and env, which 
support viral particle formation. Additionally, most 
retroviruses and complementary lines are ecotropic 
in that they infect species-specific cell lines, limiting 
risk to humans in animal experimentation (Kim, 
2002).
Embryonic Stem (ES) Cell Technology. ES cell transfer 
technologies have been used to produce either 
random or targeted insertions as well as ablation 
of discrete DNA fragments within the whole animal 
(Fig. 1). In contrast to microinjection, the use of ES 
cells was quite effective in targeting genes to specific 
chromosomal locations (Brinster et al., 1989a; 
Capecchi, 1989). Procedures for ES cell transfer 
take advantage of an in vitro selection of a specific 
chromosomal integration event via homologous 
recombination in cell cultures prior to introduction 
into preimplantation embryos (Capecchi, 1989). The 
ability to screen ES cell clones in vitro has led to 
the production of animals that a) incorporate novel 
foreign genes into their genome, b) carry modified 
endogenous genes (knock-in models), and c) lack 
specific endogenous genes (knock-out models) 
(Doetschman, 2002; Rucker et al., 2002).
Pluripotential ES cells are derived from early pre-
implantation embryos and characterized as to their 
state of differentiation (i.e., undifferentiated cells 
based on morphology, various molecular markers, 
and ability to contribute to the germline of animals) 
before in vitro manipulations. After characterization, 
ES cells are transfected with various vector systems 
to effect a given genetic modification of interest, 
and then injected directly into blastocyst stage or 
earlier stage embryos, or incubated in association 
with preimplantation stage ova (Doetschman, 2002; 
Rucker et al., 2002). The host embryos are then 
transferred into intermediate hosts or surrogate 
females for further development. The use of ES 
cells to produce transgenic mice faced a number of 
procedural obstacles before becoming competitive 
with DNA microinjection as a standard technique in 
animal modeling. Additionally, the use of co-culture 
techniques involving tetraploid host embryos (8-
cell stage to morula stage) has resulted in animals 
completely derived with ES cell genetics in one 
generation (Wood et al., 1993). Yet, while various 
ES cell lines were identified for species other than 
the mouse, the production of germline-competent ES 
cell-derived/chimeric farm animals was not reported. 
With the advent of nuclear transfer-related and 
somatic-cell technologies, the need to identify ES 
or primordial germ cells (PGCs) to induce targeted 
genetic modification has lessened considerably (see 
also Matsui et al., 1992; Piedrahita et al., 1998).
Nuclear Transfer. Nuclear transfer involves a technique 
where nuclei of various cell origins are introduced 
into enucleated oocytes (unfertilized eggs), thereby 
reprogramming future development (Fig. 3).  The 
successful cloning of a sheep was reported in the 
mid-1990s following technological difficulties in 
mouse studies in the early 1980s, and rekindling 
the imagination of researchers struggling with 
microinjection and related technologies (Wilmut et 
al., 1997). This landmark paper, followed by a number 
of technological feats, rapidly led to the production of 
transgenic domestic animals using a variety of cloning 
technologies (see also Godke et al., 2002; Paterson 
et al., 2002; Tsunoda and Kato, 2002). It should be 
noted that nuclear transfer, with nuclei obtained 
from either mammalian stem cells or differentiated 
adult cells, is an especially important development 
in species beyond the mouse model. In particular, 
a technological barrier was surpassed in allowing 
the characterization of in vitro cell cultures, and 
simultaneously obviating the difficulties in identifying 
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pluripotential farm animal stem cells. Unfortunately, 
at this time, the relative efficiencies for nuclear 
transfer experimentation still pale in comparison to 
other techniques (Pinkert et al., 2001; Honaramooz 
et al., 2002; Lavitrano et al., 2002). While nuclear 
transfer might be considered inefficient in its current 
form, major strides in enhancing experimental 
protocols have been envisioned (Godke et al., 2002; 
Paterson et al., 2002).
Sperm and Spermatogonia. In contrast to progress 
in embryo manipulation, a completely different 
avenue was taken with the advent of sperm-related 
transfer procedures. In 1989, sperm-mediated gene 
transfer was reported but hotly disputed when many 
laboratories around the world were unable to duplicate 
the outlined procedures (Brinster et al., 1989b). Yet, 
by 1994, the sperm-mediated story generated interest 
that resulted in the development of spermatogonial 
cell transplantation procedures as feasible alternatives 
for in vivo gene transfer (Brinster and Avarbock, 1994; 
Nagano et al., 2001). Additionally, studies over the 
past year have now illustrated procedures that were 
successful in transgenic pig production using either 
sperm-mediated gene transfer (Lavitrano et al., 2002) 
or spermatogonial transplantation (Honaramooz et 
al., 2002). 
Production of Transgenic Domestic Animals. The 
success of transgenic mouse experiments led a 
number of research groups to study the transfer 
of similar gene constructs into the germ-line of 
domestic animal species. These efforts have been 
directed primarily toward three general endpoints: 
improving the productivity traits of domestic food 
animal species, development of transgenic animals 
for use as bioreactors (i.e., producers of recoverable 
quantities of medically or biologically important 
proteins), and in transplantation-related modeling 
efforts. Toward these goals, a number of strategies 
have been employed, including systems designed 
to study: dominant gene expression, homologous 
recombination/gene targeting and the use of ES 
cells, efficiency of transformation of eggs or cells, 
disruption of gene expression by antisense or RNAi 
transgene constructs, gene ablation or knockout 
models, reporter genes, and marking genes for 
identification of developmental lineages. Since 1985, 
numerous studies have focused on transgenic farm 
animals created using growth-related gene constructs. 
Unfortunately, for the most part, desirable growth 
phenotypes devoid of deleterious consequences were 
not achieved because of an in ability to coordinately 
regulate gene expression  in deference to the 
ensuing cascade of endocrine events that unfolded.  In 
contrast, efforts at using farm animals as bioreactors 
or in transplantation-related efforts have continued to 
progress, although viable products have yet to pass 
regulatory approval and gain market acceptance at 
this time (see also Godke et al., 2002; Martin and 
Pinkert, 2002; Niemann et al., 2002)
Although involved and at times quite tedious, the 
steps in the development of trans genic models 
are relatively straight forward. In contrast to gene 
transfer in mice, the efficiency associated with the 
production of transgenic livestock, including swine, 
remains low (Martin and Pinkert, 2002). However, 
two advantages offered by swine over other domestic 
species include a favorable response to hormonal 
superovulation protocols (20-30 ova can be collected 
on average) and as a polytocous species, they have a 
uterine capacity to nurture more offspring to term. 
 For studies where the pig may be the desired model, 
the use of outbred domestic pigs is the most practical 
way to produce transgenic founders. However, 
miniature or laboratory swine are now used with 
increasing frequency in biomedical research, where 
their well-characterized background genetics make 
them more suitable for human modeling studies 
(e.g., xenotrans plant ation research). Reproductive 
efficiency in miniature swine is low compared to 
commercial swine and is character ized by a low 
ovulation rate, low birth weight and small litter size. 
Estrous cycles and gestation length are similar to 
standard commercial swine, though sexual maturity 
in males and females actually occurs between 4 and 
6 months of age in some breeds.  This is significantly 
earlier than observed in commercial swine; thereby 
hastening the generational interval.
In comparison to swine modeling, the relative 
experimental efficiencies associated with the 
production of transgenic ruminants (including 
goats, sheep and cattle) are even lower (Rexroad 
and Hawk, 1994; Niemann et al., 2002). While the 
different techniques from DNA microinjection to 
nuclear transfer require a large number of embryos to 
ensure varying levels of success, there are a number 
of pertinent considerations that will influence 
experimental yields. Such factors include the rate 
of embryo survival following manipulation, uterine 
capacity (generally these species are monotocous), 
generational interval, and animal maintenance, all 
impacting on experimental costs and efficiencies. In 
many laboratories, in vitro maturation (IVM), in vitro 
fertilization (IVF) and culture of ova (in surrogate 
hosts or incubators, although culture conditions are 
not optimal for embryo survival at this time) prior 
to final transfer aid in maximizing resources for 
production of genetically engineered ruminants. 
EVOLVING TECHNOLOGIES
Nuclear Genes. Today, DNA microinjection, retroviral 
transfection, nuclear transfer and passive transfer 
procedures (e.g., sperm-mediated transfer) have been 
used to successfully produce transgenic livestock 
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(Fig. 2 & 3). Our genetic engineering capabilities 
will continue to mature, in concert with advances in 
whole animal and somatic-cell techniques (including 
liposome-mediated gene transfer, jet injection, and 
particle bombardment), together with novel vector 
systems and innovative use of bioinformatics data. 
Envisioned progress and expansion of our existing 
knowledge base will allow us to better maximize and 
engineer production traits in farm animals in a most 
effective fashion.
From the Nucleus to the Mitochondrion. Gain-of-
function and loss-of-function modeling have, for 
the most part concentrated on introducing specific 
mutations into the nuclear genome. From a gene 
ablation standpoint, creation of loss-of-function 
models will be facilitated by the emerging technology 
of RNA interference (RNAi). Short, interfering RNA 
(siRNA) exists in a double-stranded state and inhibits 
endogenous genes (and/or exogenous sequences as 
in viral genes) due to a complementary sequence 
homology (Fire et al., 1998; Hamilton and Baulcombe, 
1999). RNAi technology has potential agricultural 
applications including the inhibition of viral gene 
transcription and inhibition of endogenous genes 
coding for deleterious gene products (Novina et 
al., 2002). Transgenic mouse and rat models using 
RNA interference were germline competent and did 
recapitulate null phenotypes (Hasuwa et al., 2002).
Using the mouse as a basis for comparison, RNAi has 
several advantages over homologous recombination/
ES cell mediated gene knock-out methodologies. 
Construction of an RNAi DNA fragment can 
be synthesized directly (including a small RNA 
Polymerase III promoter) avoiding time consuming 
and laborious cloning steps. Similarly, confirmation 
of homologous recombination in ES cell clones by 
PCR or Southern analysis would be obviated. Beyond 
nuclear transfer, this methodology provides the most 
significant advance or alternative for efficient loss-of-
function experimentation for farm animal species at 
this time (either knock-out models or decreasing gene 
expression in quantitative terms).
In contrast to various methods to target modification 
of the nuclear genome, until recently, little attention 
was focused on the importance of mitochondrial 
genetics and the mitochondrial genome in animal 
production. This omission, in part, related to the 
difficulty associated with in vivo mitochondrial 
transfer.  Without an approach in hand, a significant 
techno log ical hurdle remained in the identification 
of mitochondrial gene targets appropriate for 
engineering or modification. In domestic animals, 
various production traits were associated with 
specific mitochondrial populations. Long-established 
cytoplasmic-based traits (inferring mitochondrially-
controlled or regulated traits) in domestic animals 
have included growth, reproduction and lactation. 
In addition, mitochondrial restriction fragment 
length polymorphisms (RFLPs) were identified and 
associated with specific lactational characteristics 
in a number of dairy cattle lineages (Brown et al., 
1989; Koehler et al., 1991). Most recently, productivity 
and adaptability-related characteristics were explored 
in cloning studies that resulted in complete 
mitochondrial transfer in cattle (Bos Taurus:Bos 
Indicus; Meirelles et al., 2001). Therefore, for a 
host of applications, the ability to manipulate the 
mitochondrial genome and to regulate mitochondrial 
gene function would provide an additional target in 
modifying mammalian development.
We and others have initiated studies revolving around 
mitochondrial transfer and techniques to produce 
animals harboring foreign mitochondrial genomes 
(Pinkert et al., 1997a; Irwin et al., 1999, 2001; Levy et 
al., 1999; Marchington et al., 1999; Inoue et al., 1999; 
Sligh et al., 2000; Meirelles et al., 2001; Pinkert and 
Trounce, 2002; Takeda et al., 2002). The creation of 
transmitochondrial animals represents a new model 
system that will provide a greater understanding of 
mitochondrial dynamics, leading to the development 
of genetically engineered production animals as well 
as therapeutic strategies for human metabolic diseases 
affected by mitochondrial mutation or function. 
CONCLUSIONS AND FUTURE DIRECTIONS
Gene Transfer and Genetic Engineering Today. 
The expertise and effort associated with genetic 
modification in farm animals have proven significant 
and most challenging. Innovative solutions to 
enhance experimental efficiencies in domestic 
species are needed to bring potential products into 
the marketplace and every day usage. The outlined 
techniques for genetic engineering technologies 
represents what is currently envisioned and on the 
horizon for animal science. These techniques will 
continue to evolve, particularly with animal studies 
complementing targeted human bioinformatics 
and genomics inroads. In this regard, microarray 
technologies (Fig. 4), coupled with developments 
on genomic, proteomic, and metabonomic platforms 
will provide noteworthy direction in our outlook at 
modifying animal productivity and utility.
Future Directions. Much has been learned about 
various physiological processes in transgenic farm 
animals created to date. Unfortunately, the better 
production animal has not reached the marketplace 
as yet. It may very well be that creation of value-
added genetics (e.g., animals used as bioreactors 
or in biomedical modeling) may provide a stronger 
avenue for propelling transgenic technologies 
forward in the near-term. However, the pioneering 
studies performed since the mid-1980s have provided 
far reaching insights in redefining many in vivo 
regulatory and developmental processes that were 
Agric. conspec. sci. Vol. 68 (2003) No. 2
Carl A. PINKERT52
poorly understood in farm animal species. The 
utility of genetically-modified animal models still 
holds considerable promise  and the value to 
production agriculture cannot be underestimated. 
The Croatian indigenous Turopolje pig provides 
an ideal example of what might be targeted and 
feasible for genetic engineering studies in respect 
to both production agriculture and conservation 
biology (Robic et al., 1996; Dikic et al., 1999). In 
collaboration with Professors Marija Dikic and Ivan 
Juric, the Turopolje breed, found only in Europe and 
principally in Croatia, is a pig breed with important 
and useful genetic traits that might otherwise be lost 
due to its endangered status (with limited numbers 
of breeding sows in existence) and most worthy of 
further characterization and preservation. In the 
end, the development of rationale and safe food 
products, together with opportunities for establishing 
biomedical and value-added trait modifications, will 
provide demanding but exciting challenges for animal 
scientists in the 21st century. 
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